Welcome : Guest

Semler Scientific, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Semler Scientific, Inc., which is principally involved in providing Technology Solutions. Illustrated with 92 tables, the report showcases the company's recent news stories and events, key markets and market position as against its competitors operating in the industry.

Code: PCP-65350
Price: $3500
Company Type: Public
Pages: 95
Date: November 2016
Market Data Tables: 92

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Diagnostic Testing......3
Table 1: Diagnostics Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Hospitals, Independent Labs*, Physician Office Labs and Others......3
Table 2: Diagnostics Market by Segment Worldwide (2015) - Percentage Share Breakdown by Volume Sales for Hospitals, Independent Labs*, Physician Office Labs and Others......4
Table 3: Diagnostics Tests Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for BSI Gram-Negative, BSI Gram-Positive, Clostridium Difficile, Enteric, and Respiratory Virus......5
Table 4: Diagnostics Tests Market by Type in the US (2015) - Percentage Share Breakdown by Value for BSI Gram-Negative, BSI Gram-Positive, Clostridium Difficile, Enteric, and Respiratory Virus......6
Table 5: Diagnostic Test Sales by Category in the US (2015) - Percentage Market Share Breakdown by No. of Solid Tumour Patients for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......7
Table 6: Diagnostic Testing Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Ambulatory Physician Services, and Hospital Services......8
Table 7: Diagnostic Testing Market by Segment in the US (2015) - Percentage Share Breakdown by Value Sales for Hospital Outreach, Independent Labs, Inpatient, Outpatient, POLs, and Others......9
Table 8: Diagnostic Testing Sales by Category in the US (2015) - Percentage Share Breakdown by Value for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......10
Respiratory Drugs......11
Table 9: Respiratory Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Prevention, Rescue, and Rhinitis......11
Table 10: Respiratory Therapeutic Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Prevention, Rescue and Rhinitis......12
Bone Disease......13
Table 11: Bone Disease Drugs Market by Therapy Worldwide (2015) - Percentage Share Breakdown by Value Sales for Bisphosphonates, Bone Oncology, Hormonal Agents, SERMS, and Others......13
Diabetes......14
Table 12: Diabetes Market by Region Worldwide (2015) - Percentage Share Breakdown for Africa, Europe, Middle East & North Africa, North America & Caribbean, Southeast Asia, and Western Pacific......14
Table 13: Diabetes Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Insulin Type‐1 Diabetes, Insulin Type‐2 Diabetes, Dipeptidyl Peptidase 4, (DPP4), Glucagon-like Peptide-1 (GLP‐1), Dipeptidyl Peptidase 4, (DPP4) + Biguanide, and Others* (includes Sodium-Glucose Co-Transporter-2 (SGLT2), Biguanide, Sulfonylurea, Alpha-Glucosidase Inhibitors, Peroxisome Proliferator-Activated Receptor (PPAR)......15
Table 14: Diabetes Care Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Human Insulins, Modern Insulins, Victoza, and Others......16
Table 15: Type-II Diabetes Treatments Market Worldwide (2015-2020) in US$ Million......17
Table 16: Type II Diabetes Market by Treatment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-IV Inhibitors, GLP-1 Agonists, SGLT-2 Inhibitors and Thiazolidinediones......18
Table 17: Type II Diabetes Market by Insulin Treatment Worldwide (2015) - Percentage Share Breakdown by Value for Diet and Exercise Only, Insulin and Orals and Insulin Only......19
Table 18: Diabetes Healthcare Market by Category in the US (2015) - Percentage Share Breakdown by Value for Anti -Diabetic Agents & Supplies, Doctor Office Visits, Hospital Care, Nursing/Residential Facility Stays, Prescription Medication, and Others......20
Table 19: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown for Insulin Pumps, and Multiple Daily Injections......21
Table 20: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown by Value for Type 1, and Type 2......22
Table 21: No. of Diabetes Patients by Medication in the US (2015) - Percentage Share Breakdown for Insulin and Oral Medication, Insulin Only, No Medication, and Oral Medication Only......23
Diabetes Drugs......24
Table 22: Diabetes Drug Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-4 Inhibitor, GK Activator, GLP-1 Agonist, GPCR Agonist, IL- Receptor Antagonist, Insulin Analogue, PPAR Agonist, SGLT-2 Inhibitor, and Others......24
Table 23: Diabetes/Metabolic Drugs Market by Category Worldwide (2015) - Percentage Breakdown by Value Sales for DPP-IV Inhibitors, Glitazones, GLP-1 Analogs, Insulins, Sulfonylureas, and Others......25
Table 24: Anti-Diabetic Drug Market by Treatment Class Worldwide (2015) - Percentage Share Breakdown by Value for Diet & Exercise, Incretion, Insulin and Oral Anti-Diabetic......26
Table 25: Antidiabetes Molecules Market by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Metformin, Sulfonylureas, Thiazolidin Ediones and Others......27
Table 26: Anti-Diabetic Drugs Market in China (2015-2020) in RMB Million......28
Table 27: Diabetic Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Biguanides, Glinide, Insulin, Sulfonylureas, α-glucosidase Inhibitor, and Others......29
Table 28: Anti-Diabetic Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Insulin Drugs and Non-Insulin Drugs......30
Table 29: Diabetes Drugs Market by Product Category in China (2015) - Percentage Share Breakdown by Value for Acarbose, Insulin, Melbine, and Other Diabetes Drugs......31
Table 30: Diabetic Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value for DPP-IV & SGLT-2, GLP-1, Insulins, and Others......32
Table 31: Diabetic Drugs Market by Non-Insulin Therapy in the US (2015) - Percentage Share Breakdown by Volume for Biguanides, DPP-4 Inhibitor, Human GLP-1 Analogs, SGLT-2 Inhibitor, Sulfonylureas, and Others......33
Table 32: Oral Diabetes Medicine Market in the US (2015) - Percentage Share Breakdown by Value Sales for Dipeptidyl Peptidase-4 (DPP4), Metformin, Sulfonylureas, and Others......34
Non-Insulin Anti-Diabetic Drugs......35
Table 33: Non-Insulin Anti-Diabetic Drugs Market by Product in China (2015) - Percentage Share Breakdown by Value for Biguanides, Glucosidase Inhibitors, Nateglinide, Sulfonylurea and Others......35
Diabetic Macular Edema (DME)......36
Table 34: Diabetic Macular Edema (DME) Market by Drug Treatment Worldwide (2015) - Percentage Share Breakdown by Volume for Avastin, Laser Photocoagulation, Lucentis 0.3 mg, Steroids and Others......36
Table 35: Diabetic Macular Edema (DME) Anti Vascular Endothelial Growth Factor (VEGF) Market by Segment in the US (2015) - Percentage Share Breakdown by Volume for Avastin, Lucentis and Others......37
Insulin......38
Table 36: Insulin Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Aspart (Novolog), Detemir (Levemir), Glargine (Lantus), Glulisine (Apidra), Lispro (Humalog), and Rh Insulin......38
Table 37: Insulin Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Basal Insulins, Prandial Insulins and Pre-Mixed Insulin......39
Table 38: Insulin Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Fast Acting, Long Acting and Premix......40
Table 39: Insulin Market by Generation in China (2015) - Percentage Share Breakdown by Value for 1st Generation, 2nd Generation, and 3rd Generation......41
Table 40: Insulin Market by Product Type in the US (2015) - Percentage Share Breakdown by Value for Fast-Acting, Human, Long-Acting and Mix......42
DPP-4 Inhibitors......43
Table 41: DPP-4 Inhibitors Market by Product Category Worldwide (2015) - Percentage Share Breakdown by Value for Galvus & Galvumet (Novartis), Januvia & Janumet (MRK), Nesina & Kezano (Takeda), Onglyza & Kombiglyze (AZN/BMY) and Tradjenta & Jentadueto (BI/Lilly)......43
Table 42: DPP-4 Inhibitors Market in China (2015-2020) in RMB Million......44
Table 43: DPP-4 Inhibitors (Fixed Dose) Market by Product Category in Korea (2015) - Percentage Share Breakdown by Value for Galvusmet, Janumet, Janumet XR, Kombiglyze, Trajenta Duo and Zemimet......45
Table 44: DPP-4 Inhibitors (Non-fixed Dose) Market by Product Category in Korea (2015) - Percentage Share Breakdown by Value for Januvia, Nesina, Tradjenta, Zemiglo, and Others......46
Table 45: DPP-4 Inhibitors Market by Prescription in the US (2015) - Percentage Share Breakdown by Volume for Janumet (Sitagliptin + Metformin), Januvia (Sitagliptin), Kombiglyze XR (Saxagliptin + Metformin), Onglyza (Saxagliptin), and Others......47
Table 46: DPP-4 Inhibitors Market in the US (2015) in No. of Prescriptions......48
DPP-4 type Diabetes Drugs......49
Table 47: DPP-4 type Diabetes Drugs Market in Japan (2015) in Yen Million......49
Healthcare Institutions......50
Table 48: Healthcare Institutions Market by Category in China (2015) - Percentage Share Breakdown by Value Sales for Hospitals, Primary Healthcare Clinics and Others......50
Healthcare Services......51
Table 49: Health Services Market by Segment in Canada (2015) - Percentage Share Breakdown by Value for Drugs, Hospitals, Physicians, and Others......51
Table 50: Healthcare Service Provider System Market by Type in China (2015) - Percentage Share Breakdown by Value for Hospitals, Primary Healthcare Clinics and Others......52
Table 51: Healthcare Services Market by Segment in the US (2015) - Percentage Share Breakdown by Value for For Profit Hospitals and Others......53
Patient Care Physician Market......54
Table 52: Patient Care Physician Market for Age Group (0-17 Years) by Specialty in the US (2015) - Percentage Share Breakdown by No. of Patients for Medical Specialties, Primary Care, Surgery, and Other Care......54
Table 53: Patient Care Physician Market for Age Group (18-24 Years) by Specialty in the US (2015) - Percentage Share Breakdown by No. of Patients for Medical Specialties, Primary Care, Surgery, and Other Care......55
Table 54: Patient Care Physician Market for Age Group (25-44 Years) by Specialty in the US (2015) - Percentage Share Breakdown by No. of Patients for Medical Specialties, Primary Care, Surgery, and Other Care......56
Table 55: Patient Care Physician Market for Age Group (45-64 Years) by Specialty in the US (2015) - Percentage Share Breakdown by No. of Patients for Medical Specialties, Primary Care, Surgery, and Other Care......57
Table 56: Patient Care Physician Market for Age Group (65-74 Years) by Specialty in the US (2015) - Percentage Share Breakdown by No. of Patients for Medical Specialties, Primary Care, Surgery, and Other Care......58
Table 57: Patient Care Physician Market for Age Group (75+ Years) by Specialty in the US (2015) - Percentage Share Breakdown by No. of Patients for Medical Specialties, Primary Care, Surgery, and Other Care......59
Table 58: Physician Market for Patient Care by Type in the US (2015) - Percentage Share Breakdown by No. of Patients for Non-Primary Care and Primary Care......60
Physician Services......61
Table 59: Physician Practice Setting by Category Worldwide (2015) - Percentage Market Share Breakdown by Value for Administration/ Teaching and Research, Hospital Physician Staff, Hospital Residency/ Fellowship and Office Based......61
Table 60: Physician Market by Specialty in the US (2015) - Percentage Share Breakdown by No. of Patients for Anesthesiology, Emergency Medicine, Pathology, Psychiatry, Radiology, and Others......62
Table 61: No. of Physicians by Category in the US (2015) - Percentage Market Share Breakdown for Anesthesiology, Emergency Medicine, Family Medicine, General Practice, Hospitalists, Neonatal-Perinatal Medicine, and Others......63
Table 62: Physicians for Primary Care Market by Specialty in the US (2015) - Percentage Share Breakdown by No. of Patients for General Family Practice, General Internal Medicine, and Pediatrics......64
Diagnostic Testing......65
Table 63: Market Shares of Leading Diagnostic Testing Companies in the US (2015) - Percentage Share Breakdown by Value for Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated and Others......65
Respiratory Therapeutics......66
Table 64: Market Shares of Leading Respiratory Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......66
Bone Disease......67
Table 65: Market Shares of Leading Bone Diseases Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Amgen, Inc., Eli Lilly and Company, GlaxoSmithKline Plc, Merck Ltd., Novartis AG, Pfizer, Inc., F. Hoffmann-La Roche AG, Sanofi S.A., and Others......67
Table 66: Market Shares of Leading Therapeutic Providers (Alzheimer's Disease, Bone Diseases, Cardiology, CNS, Dermatology, Diabetes/Metabolic, Epilepsy, G.I./Ulcer, HBV/HCV, Infectious Disease, Multiple Sclerosis, Obesity, Onc./Hematology, Ophthalmology, Orphan Disease, Pain Management, Respiratory, Rheumatology, Sleep Disorders, Urinary Incont., and Women's Health) by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Biogen Idec, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Endo International Plc, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......68
Diabetes Drugs......69
Table 67: Market Shares of Leading Diabetes Care Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Bristol-Myers Squibb (Incl Amylin), Eli Lilly and Company, Merck & Co., Inc., Novo Nordisk A/S, Sanofi S.A. and Others......69
Table 68: Market Shares of Leading Diabetes Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......70
Table 69: Market Shares of Leading Anti-Diabetic Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Abbott Healthcare Pvt Ltd., Biocon Limited, Lupin Pharmaceuticals, Inc., MSD Pharmaceuticals Private Limited, Sanofi-Aventis Groupe, Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., and Others......71
Insulin......72
Table 70: Market Shares of Leading Insulin Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Eli Lilly and Company, Novo Nordisk A/S, Sanofi S.A., and Others......72
Table 71: Market Shares of Leading Insulin Companies Worldwide (2014) - Percentage Breakdown by Volume Sales for Eli Lilly and Company, Novo Nordisk A/S, Sanofi S.A., and Others......73
Table 72: Market Shares of Leading Fast & Intermediate Type Insulin Producers Worldwide (2015) - Percentage Share Breakdown by Value for Eli Lilly and Company, Novo Nordisk, Sanofi S.A. and Others......74
Table 73: Market Shares of Leading Long-Acting Insulin Producing Companies Worldwide (2015) - Percentage Share Breakdown by Value for Sanofi S.A., Wockhardt Ltd., and Others......75
Table 74: Market Shares of Leading Insulin Companies in China (2014) - Percentage Share Breakdown by Value for Eli Lilly and Company, GanLee Pharmaceutical Co., Ltd., Novo Nordisk, Sanofi S.A., Shanghai Fosun Pharmaceutical Group Co., Ltd., United Laboratories International Holdings Ltd. (The), Tonghua Dongbao Pharmaceutical Co., Ltd., and Others......76
Table 75: Market Shares of Leading Insulin Companies in China (2015) - Percentage Share Breakdown by Volume for Novo Nordisk, Tonghua Dongbao Pharmaceutical Co., Ltd., Wanbang Biopharmaceuticals Co., Ltd. and Others......77
Table 76: Market Shares of Leading Insulin Companies in Europe (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S, and Others......78
Table 77: Market Shares of Leading Insulin Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Biocon Ltd., Cadila Pharmaceuticals Ltd., Eli Lilly and Company India Pvt. Ltd., Lupin Pharmaceuticals, Inc., Novo Nordisk India Ltd., Pfizer India Ltd., Ranbaxy Laboratories Ltd., Sanofi India Ltd., Shreya Life Sciences Pvt. Ltd., USV Ltd., and Wockhardt Ltd.......79
Table 78: Market Shares of Leading Insulin Companies in Japan and Korea (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S, and Others......80
Table 79: Market Shares of Leading Insulin Companies in North America (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S, and Others......81
Second-Generation Insulin......82
Table 80: Market Shares of Leading Second-Generation Insulin Companies in China (2014) - Percentage Share Breakdown by Volume for Eli Lilly and Company, Novo Nordisk, The United Laboratories International Holdings, Ltd., and Tonghua Dongbao Pharmaceutical Co., Ltd.......82
Third-Generation Insulin......83
Table 81: Market Shares of Leading Third-Generation Insulin Companies in China (2014) - Percentage Share Breakdown by Volume for Eli Lilly and Company, Gan & Lee Pharmaceutical, Ltd., Novo Nordisk, and Sanofi S.A.......83
Human Insulin......84
Table 82: Market Shares of Leading Human Insulin Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Biocon Limited, Eli Lilly and Company India Pvt. Ltd., Novo Nordisk India Limited, Sanofi India Limited, Wockhardt Ltd., and Others......84
DPP-4 Inhibitors......85
Table 83: Market Shares of Leading DPP-4 Inhibitors Manufacturers by Value Sales Worldwide (2015) - Percentage Share Breakdown for Merck & Co., Inc. (Januvia/Janumet), Novartis AG (Galvus/Galvumet) and Takeda Pharmaceutical Co., Ltd. (Nesina/Kezano), and Others......85
Table 84: Market Shares of Leading DPP-4 Inhibitors for Treatment of Diabetes in Japan (2015) - Percentage Share Breakdown by Value for Equa, Glactiv, Januvia, Nesina, and Others......86
Table 85: Market Shares of Leading DPP-4 Drug Brands in China (2015) - Percentage Share Breakdown by Value for Galvus, Januvia, Onglyza, and Others......87
Sitagliptin/Metformin......88
Table 86: Market Shares of Leading Sitagliptin Brands by Value Sales in India (2015) - Percentage Share Breakdown for Istavel and Januvia......88
Table 87: Market Shares of Leading Sitagliptin Manufacturers by Value Sales in India (2015) - Percentage Share Breakdown for Merck & Co., Inc. and Sun Pharmaceutical Industries Ltd.......89
Table 88: Market Shares of Leading Sitagliptin/Metformin Brands by Value Sales in India (2015) - Percentage Share Breakdown for Janumet, and Others......90
Table 89: Market Shares of Leading Sitagliptin/Metformin Manufacturers by Value Sales in India (2015) - Percentage Share Breakdown for Merck & Co., Inc., and Others......91
Metformin......92
Table 90: Market Shares of Leading Metformin Suppliers in India (2015) - Percentage Share Breakdown by Value for Harman Finochem Ltd., USV Pharmaceuticals Ltd., Wanbury Limited and Others......92
Healthcare Services......93
Table 91: Market Shares of Leading Health Care Service Providers in the US (2015) - Percentage Breakdown by Purchasing Volume for Amerinet, Inc., HealthTrust, LLC, MedAssets, Inc., Novation, LLC, Premier Healthcare, LLC, and Others......93
Physician Distribution......94
Table 92: Market Shares of Leading Physician Distribution Companies Worldwide (2014) - Percentage Breakdown by Value for Cardinal Health, Inc., Henry Schein, Inc., Man Direct, McKesson Corporation PSS World Medical, Inc., and Local and Regional......94